Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets

Despite great histological and molecular heterogeneity, the clinical management of high-grade ovarian carcinomas remains unspecialized. As a major subgroup, high-grade serous ovarian carcinomas (HGSOCs) require novel therapies. In addition to utilizing conventional histological prognostic markers an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuhui, Cavazza, Elisa, Barlier, Catherine, Salleron, Julia, Filhine-Tresarrieu, Pierre, Gavoilles, Céline, Merlin, Jean-Louis, Harlé, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103928/
https://www.ncbi.nlm.nih.gov/pubmed/27899992
http://dx.doi.org/10.3892/ol.2016.5083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103928/
https://www.ncbi.nlm.nih.gov/pubmed/27899992
http://dx.doi.org/10.3892/ol.2016.5083

Ejemplares similares